In Pain relief Nucoxia D3 Capsule relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis, osteoarthritis, ankylosing spondolytis and gout. It is also used for the short term treatment of moderate pain after dental surgery. Taking Nucoxia D3 Capsule will help in speedy recovery and make you feel better. Vitamin D3 present in Nucoxia D3 Capsule helps in building strong bones and thus reduce risk of any bone disorders. Take it as it is prescribed to get the most benefit. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
It is unsafe to consume alcohol with Nucoxia D3 Capsule.
Nucoxia D3 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Nucoxia D3 Capsule during breastfeeding is not available. Please consult your doctor.
Nucoxia D3 Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nucoxia D3 Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nucoxia D3 Capsule may not be needed in these patients. Please consult your doctor.
Nucoxia D3 Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nucoxia D3 Capsule may not be needed in these patients. Please consult your doctor.
If you miss a dose of Nucoxia D3 Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More